about
ATRX directs binding of PRC2 to Xist RNA and Polycomb targetsEvolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsTargeting histone methyltransferases and demethylases in clinical trials for cancer therapyEnvironmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer PreventionRedox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequencesSynthesis of lysine methyltransferase inhibitorsChemical probes of histone lysine methyltransferasesBack to the future: transgenerational transmission of xenobiotic-induced epigenetic remodelingEpigenetic Mechanisms of Serotonin Signaling.Extracellular Forces Cause the Nucleus to Deform in a Highly Controlled Anisotropic Manner.8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase InhibitorsA PWWP domain-containing protein targets the NuA3 acetyltransferase complex via histone H3 lysine 36 trimethylation to coordinate transcriptional elongation at coding regions.Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapiesReactive oxygen species and fibrosis: further evidence of a significant liaisonEZH2 in Bladder Cancer, a Promising Therapeutic TargetKDM1 class flavin-dependent protein lysine demethylasesDiscovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8Initiation of diverse epigenetic states during nuclear programming of the Drosophila body planAnimal models of gene-environment interaction in schizophrenia: A dimensional perspective.Quantitative proteomic analysis of histone modificationsEpigenetic regulation in the inner ear and its potential roles in development, protection, and regeneration.Discovering and understanding oncogenic gene fusions through data intensive computational approachesTranscriptional Regulation of Arabidopsis Polycomb Repressive Complex 2 Coordinates Cell-Type Proliferation and Differentiation.Vitamin D and the epigenome.JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.Chromatin modifications during repair of environmental exposure-induced DNA damage: a potential mechanism for stable epigenetic alterations.Influence of oncogenic transcription factors on chromatin conformation and implications in prostate cancer.Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.Chromatin Regulates Genome Targeting with Cisplatin.Regulatory interactions between RNA and polycomb repressive complex 2.Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.Epigenetic control of gene function in schistosomes: a source of therapeutic targets?Epigenetic mechanisms in heart failure pathogenesisDisruption of crosstalk between mesenchymal stromal and tumor cells in bone marrow as a therapeutic target to prevent metastatic bone disease.The nexus of chromatin regulation and intermediary metabolism.SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancerEpigenetic mechanisms in schizophrenia.Epigenetic drugs against cancer: an evolving landscape.The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.Pathobiology of liver fibrosis: a translational success story
P2860
Q24307468-4171CC62-9D0B-4FE3-A954-343B19D8E241Q26745566-D0D3FE27-B40D-4522-BC47-8DD59233B249Q26746038-3CAA6005-A0A6-490A-9446-9929A8E40776Q26784500-7342538D-B66E-4580-90CE-63E82631FEDDQ26786129-F1FA424E-0B1A-42EE-B18E-D2B24F83298FQ26799953-6AC83B49-D9D1-4AA6-B01A-3E3908F9C1F5Q26829218-184A30C6-9BF7-41CA-BD15-964882F1CD6DQ26852391-C5F26376-A87B-4821-B101-F3D957A546EAQ27027985-A0F54012-B877-4AE9-AAD0-22BB155EA08FQ27348514-FF38A658-7910-4D92-8E78-BC9D21ADDFD4Q27644640-6F0AE182-1A3C-46C9-94A6-E0C2BD79BC7FQ27935497-96D17DBD-12EE-419B-8434-6537BC3E7207Q28074716-7790A721-A2E4-4D35-9FE2-3A74EAA01BB2Q28077930-5C38CC56-C381-42F8-BFDD-158B115B7E63Q28082054-49B439A6-C77C-4C79-8E96-EC7A992ADCB5Q28084876-77EB31BE-C76B-4659-8AFB-6D88111F4804Q28244062-8DE2B3C0-DAB6-435A-9851-06C0ADA2DC4EQ28830931-4032F3D8-DB7B-48EC-96F0-560AE4F3CE26Q30367009-A9F89437-3461-465B-9803-7740730D064CQ30375585-A93BDD2A-4502-44AB-9CA8-D175C70FB277Q30417109-6FE84843-D6E6-41BE-9253-19882871176FQ31083417-7E91FF35-481E-4D61-A677-9F1CCAD0463CQ33363898-E7C961CF-BD49-45F6-9A2F-86ECF25FC997Q33569349-C0BF9F51-885A-47C8-9ECC-84D4757F965CQ33591745-5D3C0997-056B-44A8-AABA-6EB101856814Q33606592-124F2065-1B93-4E96-AC0D-8641A8986EDEQ33675577-459617A1-3A08-42D5-9C48-36B3D3638966Q33762936-721609C9-B093-4903-9748-EA262BCD86FEQ33845705-8C1F5996-FD35-4EB6-858A-10712401111CQ33938354-4A7C71F9-D920-4A36-A610-2EE41D337690Q34034234-4BC97CE8-66A8-49BD-820E-4F7ACE895C95Q34159188-DCEF6CA1-A9D9-4E49-B921-CBDFBD4861A0Q34212728-F38A43DB-D34D-45E3-B5DB-99EEF6CD0A69Q34307763-084CE1BF-BFEC-4C6B-AE7D-C1E65FC7D530Q34379834-D30BA28B-0424-403F-8E3E-58BAB8BC87B8Q34420873-8931DF74-58E3-462E-BCC4-FFA0439A0B84Q34426222-BCF47BE4-2239-4909-BB75-0B3ED42B28C9Q34431964-3E2703D5-7DC0-4375-83FF-3282DD6C31CBQ34459061-2B924A37-55CE-4FA9-8666-6B97747DC63BQ34462733-7F41634C-7BEE-4153-84BF-19052A32957C
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chromatin proteins and modifications as drug targets.
@ast
Chromatin proteins and modifications as drug targets.
@en
Chromatin proteins and modifications as drug targets.
@nl
type
label
Chromatin proteins and modifications as drug targets.
@ast
Chromatin proteins and modifications as drug targets.
@en
Chromatin proteins and modifications as drug targets.
@nl
prefLabel
Chromatin proteins and modifications as drug targets.
@ast
Chromatin proteins and modifications as drug targets.
@en
Chromatin proteins and modifications as drug targets.
@nl
P2860
P356
P1433
P1476
Chromatin proteins and modifications as drug targets.
@en
P2093
Dashyant Dhanak
P2860
P2888
P304
P356
10.1038/NATURE12751
P407
P577
2013-10-01T00:00:00Z